News >

Assessing Strategies and Challenges in Newly Diagnosed and Recurrent Ovarian Cancer

Caroline Seymour
Published: Monday, Aug 05, 2019

Jeannie Chern, MD, gynecologic oncologist, Moffitt Cancer Center

Jeannie Chern, MD

There is no clear directive regarding the proper makeup of available treatment modalities in the recurrent setting of ovarian cancer, particularly when it comes to secondary cytoreductive surgery, explained Jeannie Chern, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Oncology Briefings™: A Nurses' Guide to Managing Adverse Events Associated with PARP InhibitorsJun 30, 20201.0
Publication Bottom Border
Border Publication